Figure 5

The Xenograft and genetically engineered mouse model (GEMM). In Xenograft mouse models, cancer cells are generally injected subcutaneously into immunodeficient mice. Oncogenes in GEMM are activated and/or tumour-suppressor genes (TSGs) are inactivated somatically.